Y-Intercept (HK)’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $736K | Sell |
10,668
-237,147
| -96% | -$16.4M | 0.02% | 1071 |
|
|
2025
Q1 | $17.2M | Buy |
247,815
+122,734
| +98% | +$8.52M | 1.17% | 1 |
|
|
2024
Q4 | $10.8M | Buy |
125,081
+83,364
| +200% | +$7.17M | 0.72% | 7 |
|
|
2024
Q3 | $4.97M | Buy |
+41,717
| New | +$4.97M | 0.3% | 48 |
|
|
2024
Q2 | – | Sell |
-16,192
| Closed | -$2.08M | – | 1759 |
|
|
2024
Q1 | $2.08M | Sell |
16,192
-9,238
| -36% | -$1.19M | 0.16% | 162 |
|
|
2023
Q4 | $2.63M | Buy |
25,430
+1,778
| +8% | +$184K | 0.24% | 92 |
|
|
2023
Q3 | $2.15M | Buy |
23,652
+3,894
| +20% | +$354K | 0.21% | 126 |
|
|
2023
Q2 | $1.6M | Buy |
+19,758
| New | +$1.6M | 0.17% | 150 |
|
|
2022
Q3 | – | Sell |
-18,556
| Closed | -$1.03M | – | 1183 |
|
|
2022
Q2 | $1.03M | Buy |
+18,556
| New | +$1.03M | 0.14% | 218 |
|
|
2021
Q4 | – | Sell |
-49,664
| Closed | -$2.38M | – | 792 |
|
|
2021
Q3 | $2.38M | Buy |
+49,664
| New | +$2.38M | 0.43% | 43 |
|
|
2021
Q2 | – | Sell |
-18,478
| Closed | -$628K | – | 811 |
|
|
2021
Q1 | $628K | Buy |
18,478
+9,494
| +106% | +$323K | 0.17% | 193 |
|
|
2020
Q4 | $315K | Buy |
+8,984
| New | +$315K | 0.13% | 297 |
|